PPLPHARMA
Piramal Pharma Limited
Pharmaceuticals
Share price
₹239
Market cap
₹31,853 Cr
1Y return
▲ 26%
A pharmaceutical company operating across three major segments: contract development and manufacturing organisations, complex hospital generics for critical care, and consumer healthcare products. Established through the acquisition of Nicholas Laboratories in 1988, the company has expanded via strategic mergers and acquisitions alongside organic growth initiatives. It serves healthcare providers and consumers across India through its diversified business operations and specialized pharmaceutical solutions.
Investors holding Piramal Pharma Limited
Recent moves 6
1move in the last 30 days
Members onlyNippon India Mutual FundNew position
Nippon India Mutual Fund added over 0.56% of Piramal Pharma and now holds 1.56% of the company, representing 2,07,58,801 shares.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma from 7.68% to 5.65%, selling 2,70,61,536 shares.
Read more
Canara Robeco Mutual FundExited
Canara Robeco Mutual Fund, which last reported a 1.0 percent stake in Piramal Pharma Limited, is no longer on the list of disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma Limited from 9.37% to 7.68%, selling 22,260,933 shares.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma from 9.02% to 7.01%, selling 2,66,88,471 shares via open market on July 14, 2026.
Read more
Track the whales in Piramal Pharma Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1